Search - tctmd.com

Displaying 21 - 40 of 197

Sort: Relevancy | Date

News Daily News

Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles

Michael O'Riordan

May 12, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Conference News AHA 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

Todd Neale

November 18, 2019

Presentation AHA 2019

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

Presenter: Matthew Budoff

November 18, 2019

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Daily News

Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes

Todd Neale

April 11, 2019

News Daily News

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Todd Neale

February 18, 2019

News Daily News

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

Michael O'Riordan

December 10, 2018

News Daily News

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

L.A. McKeown

October 16, 2018

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Conference News ACC 2018

Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later

Caitlin E. Cox

February 28, 2018

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Podcast TCTMD Talking Points

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

October 18, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

Presentation SCCT 2017

Calcium Progression and Warranty Periods: A Role for Repeat Scanning

Presenter: Matthew Budoff

July 13, 2017

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Daily News

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Yael L. Maxwell

June 16, 2017

Advertisement

Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Calcium Progression and Warranty Periods: A Role for Repeat Scanning

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Differences in Inter-Arm Blood Pressure Seem to Correlate With CAD Severity

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content